3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
2
Breast Neoplasms
2
Smoldering Multiple Myeloma
1
Psychological Well-Being
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
Multiple Myeloma
1
Motor Activity
1
Monoclonal Gammopathy of Undetermined Significance
1
Lung Neoplasms
1
Limited Stage Small Cell Lung Cancer
1
Helicobacter Infections
1
Fatigue Syndrome, Chronic
1
Esophageal Neoplasms
1
Diarrhea
1
Breast Carcinoma In Situ
1
Interventions
Exercise
34
Nutritional Status
5
Control Groups
4
Resistance Training
3
High-Intensity Interval Training
3
lime
2
Vitamin D
2
Standard of Care
2
Preoperative Exercise
2
Dosage Forms
2
Diet
2
tislelizumab
1
pembrolizumab
1
oncomodulin
1
diacetamate
1
blueberry extract
1
beta-Glucans
1
Whey Proteins
1
Wearable Electronic Devices
1
Walking
1
Transcranial Direct Current Stimulation
1
Tea
1
Tablets
1
TEMPO
1
Spermine Synthase
1
Roflumilast
1
Rehabilitation
1
Probiotics
1
Physical Therapy Modalities
1
Physical Examination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Motor Activity
×
Probiotics
×
Clear all
NCT04871412
2026-01-30
POISE
Ottawa Hospital Research Institute
Phase 3
Recruiting
20 enrolled